InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
61,075.77
(
0.46%
)
Post# of 39884
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Avoid

Send PM Follow Ignore
Followers 23
Posts 1671
Boards Moderated 0
Alias Born 09/04/2009

Avoid

Re: None

Thursday, 03/23/2017 10:09:11 AM

Thursday, March 23, 2017 10:09:11 AM

Post# of 39884
(NASDAQ: TRPX) IPO cannabinoid-based drugs

TEL AVIV, Israel, March 22, 2017 /PRNewswire/ --

Therapix Biosciences Ltd. (NASDAQ: TRPX) (TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced the pricing of its initial public offering in the United States of 2,000,000 American Depository Shares ("ADSs"). Each ADS, representing 40 ordinary shares of the Company, is offered at a price to the public of $6.00.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up